Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

10 Information Technology Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

7 Analysts Have This to Say About Upwork

7 Analysts Have This to Say About Upwork

Analysts have provided the following ratings for Upwork (NASDAQ:UPWK) within the last quarter:

11 Stocks Moved By Traders on 'Fast Money: Halftime Report'

11 Stocks Moved By Traders on 'Fast Money: Halftime Report'

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Activision Blizzard Chief Takes Positive Step Towards Union Taking Cues From Microsoft, Amazon

Activision Blizzard, Inc (NASDAQ:ATVI) CEO Bobby Kotick shared plans to negotiate with the Communications Workers of America over a collective bargaining agreement for employees at its subsidiary Raven Software. Kotick looked to meet CWA leaders at the bargaining table and work toward an agreement. Activision Blizzard faced charges of union-busting and illegally retaliating…

14 Analysts Have This to Say About Marvell Tech

Marvell Tech (NASDAQ:MRVL) has observed the following analyst ratings within the last quarter:

Check Out What Whales Are Doing With WBD

A whale with a lot of money to spend has taken a noticeably bearish stance on Warner Bros Discovery. Looking at options history for Warner Bros.Discovery (NASDAQ:WBD) we detected 10 strange trades.

Here's What It Will Take For Netflix To Win Streaming War

Analysts grow cautious regarding Netflix, Inc (NASDAQ:NFLX) over brewing competition in the post-Covid world. Needham analyst Laura Martin saw Netflix as unlikely to win the Streaming Wars pending launch of a lower-priced ad-driven tier, adding Sports and News content, bundling with other products, and acquiring an extensive film and TV content library. Every major streaming competitor does one or…

inkl

Read news from The Economist, FT, and more,
with one subscription

Goldman Sachs Maintains Neutral Rating for Duolingo: Here's What You Need To Know

Goldman Sachs Maintains Neutral Rating for Duolingo: Here's What You Need To Know

Goldman Sachs has decided to maintain its Neutral rating of Duolingo (NASDAQ:DUOL) and lower its price target from $106.00 to $84.00. Shares of Duolingo are trading down 3.32% over the last 24 hours, at $92.96 per share. A move to $84.00 would account for a 9.64% decline from the current…

Why Meta Platforms Shares Are Falling Today

Why Meta Platforms Shares Are Falling Today

Meta Platforms Inc (NASDAQ: META) shares are trading lower by 4.65% to $175.45. Meta Platforms shares are trading lower as tech stocks pull back amid a rise in yields following worse-than-expected US CPI data.

Read Why Mizuho Re-rated Adobe Ahead Of Its 2Q Earnings

Read Why Mizuho Re-rated Adobe Ahead Of Its 2Q Earnings

Adobe Inc (NASDAQ: ADBE) will report its 2Q results on June 16, Mizuho analyst Gregg Moskowitz noted.

Analyst Ratings for MarketAxess Holdings

Analyst Ratings for MarketAxess Holdings

MarketAxess Holdings (NASDAQ:MKTX) has observed the following analyst ratings within the last quarter:

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,400 Today

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,400 Today

Copart (NASDAQ:CPRT) has outperformed the market over the past 5 years by 18.07% on an annualized basis producing an average annual return of 27.89%. Currently, Copart has a market capitalization of $25.67 billion.

What's Going On With Caribou Biosciences Shares Today?

What's Going On With Caribou Biosciences Shares Today?

Caribou Biosciences, Inc. (NASDAQ: CRBU) shares are trading lower after the company reported additional data from its CB-010 allogeneic CAR-T cell therapy Phase 1 ANTLER trial at the European Hematology Association 2022 Hybrid Congress.

Cowen & Co. Maintains Outperform Rating for Grocery Outlet Holding: Here's What You Need To Know

Cowen & Co. Maintains Outperform Rating for Grocery Outlet Holding: Here's What You Need To Know

Cowen & Co. has decided to maintain its Outperform rating of Grocery Outlet Holding (NASDAQ:GO) and raise its price target from $42.00 to $45.00. Shares of Grocery Outlet Holding are trading up 2.38% over the last 24 hours, at $37.85 per share.

Get all your
news in one place.

100's of premium titles.
One news app.

What 5 Analyst Ratings Have To Say About Cytokinetics

Within the last quarter, Cytokinetics (NASDAQ:CYTK) has observed the following analyst ratings:

Where Frontdoor Stands With Analysts

Frontdoor (NASDAQ:FTDR) has observed the following analyst ratings within the last quarter:

Peering Into Booking Holdings's Recent Short Interest

Booking Holdings's (NASDAQ:BKNG) short percent of float has fallen 5.29% since its last report. The company recently reported that it has 723.60 thousand shares sold short, which is 1.79% of all regular shares that are available for trading.

Will Investors Notice Exciting Sign On United Therapeutics's Chart?

If history is any guide, there may be good fortune ahead for shares of United Therapeutics (NASDAQ:UTHR). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Get all your
news in one place.

100's of premium titles.
One news app.

Academy Sports's Ex-Dividend Date Is Wednesday, Here's What You Need To Know

Tuesday marks the last chance for investors to receive the next dividend payout from Academy Sports (NASDAQ:ASO).

ESSA Bancorp's Ex-Dividend Date Is Wednesday, Here's What You Need To Know

Tuesday marks the last chance for investors to receive the next dividend payout from ESSA Bancorp (NASDAQ:ESSA).

Why Shares Of Cogent Biosciences Are Trading Higher

Cogent Biosciences, Inc. (NASDAQ: COGT) shares are trading higher after the company reported initial data from its ongoing Phase 2 APEX clinical trial.

2 Must-Own Tech Stocks in the Nasdaq-100

Investors’ worries about the Fed’s hawkish tilt to combat inflation have led several fundamentally sound tech stocks to plunge significantly in price this year. However, given the solid long-term prospects of the tech industry, we think it could be wise to invest in the shares of quality tech stocks in…

Why BofA Believes It's A Good Time To Buy ProFrac

ProFrac Holding Corp. (NASDAQ: PFHC) is well-positioned to benefit from a material rise in fracking profitability through year end and into 2023.

Mid-Day Market Update: Nasdaq Dips 400 Points; Cogent Biosciences Shares Jump

U.S. stocks traded lower midway through trading, with the Nasdaq Composite tumbling around 400 points on Friday.

Credit Suisse Cuts REV Group Price Target By 9%

Credit Suisse analyst Jamie Cook lowered the price target on REV Group Inc (NASDAQ:REVG) to $10 from $11 while maintaining the Underperform rating on the shares. The analyst stated that within the quarter, REVG did not experience supply chain improvement as expected, and in some instances, the situation worsened. REVG now expects supply chain challenges…

1 … 461 462 463 464

People

Gregg Moskowitz

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Warner Bros Discovery

Activision Blizzard

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

401,857 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play